Intellia Therapeutics (NTLA) EBIT Margin (2015 - 2026)
Intellia Therapeutics' EBIT Margin came in at -1472.25% for Q2 2026, down 700.08 percentage points from -772.17% a year earlier and down 804.18 percentage points from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) EBIT Margin (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Intellia Therapeutics reported EBIT Margin of -711.66%, up 257.03 percentage points year-over-year; for FY2025, it was -651.67%, up 271.43 percentage points from FY2024.
- EBIT Margin carries a five-year change of -416.16 percentage points (FY2020 to FY2025).
- Going back by year, EBIT Margin was -923.10% in FY2024 (+497.41 pp), -1420.51% in FY2023 (-541.47 pp), -879.04% in FY2022 (-68.67 pp) and -810.37% in FY2021 (-574.85 pp).
- The Q2 2026 figure represents the lowest quarterly EBIT Margin since Q3 2024.
- Year-over-year, EBIT Margin increased in four of the last seven quarters, with an average year-over-year change of +166.82 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in Q2 2025 (a gain of 1226.43 percentage points), and the weakest in Q2 2024 (a drop of 1025.13 percentage points).
- Business Quant data shows NTLA's EBIT Margin at -668.08% (Q1 2026), -428.86% (Q4 2025) and -808.86% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Intellia Therapeutics | 1.60 Bn | 1.60 Bn | - | -1,472.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,472.25% |
| Mar 31, 2026 | -668.08% |
| Dec 31, 2025 | -428.86% |
| Sep 30, 2025 | -808.86% |
| Jun 30, 2025 | -772.17% |
| Mar 31, 2025 | -726.57% |
| Dec 31, 2024 | -1,059.86% |
| Sep 30, 2024 | -1,588.96% |
| Jun 30, 2024 | -1,998.61% |
| Mar 31, 2024 | -394.00% |
| Sep 30, 2023 | -1,093.29% |
| Jun 30, 2023 | -973.47% |
| Mar 31, 2023 | -888.13% |
| Dec 31, 2022 | -811.07% |
| Sep 30, 2022 | -795.49% |
| Jun 30, 2022 | -700.65% |
| Mar 31, 2022 | -1,281.96% |
| Dec 31, 2021 | -625.60% |
| Sep 30, 2021 | -999.35% |
| Jun 30, 2021 | -1,053.69% |
API Access
Intellia Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();